Phase I/II Clinical Trial of a Nonreplicative Vaccinia Virus Expressing Multiple HLA-A0201-Restricted Tumor-Associated Epitopes and Costimulatory Molecules in Metastatic Melanoma Patients-Reference-Cited by-同舟云学术

Phase I/II Clinical Trial of a Nonreplicative Vaccinia Virus Expressing Multiple HLA-A0201-Restricted Tumor-Associated Epitopes and Costimulatory Molecules in Metastatic Melanoma Patients

Published:2003-11 Issue:16 Volume:14 Page:1497-1510
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zajac P.¹,Oertli D.²,Marti W.²,Adamina M.²,Bolli M.²,Guller U.²,Noppen C.¹,Padovan E.³,Schultz-Thater E.¹,Heberer M.¹,Spagnoli G.¹

Affiliation:

1. Institute of Surgical Research and Hospital Management, Department of Research of the University Hospital of Basel, CH-4031 Basel, Switzerland

2. Department of General Surgery, University Hospital Basel, CH-4031 Basel, Switzerland

3. Center of Experimental Rheumatology, Department of Clinical Research, Bern University Hospital, 3010 Bern, Switzerland

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303403322495016

Reference63 articles.

1. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

2. Regulation of T cell Apoptosis during the Immune Response

3. The nature and action of granulocyte-macrophage colony stimulating factors

4. Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety assessment of oncolytic virotherapies in the treatment of advanced melanoma: a systematic review and meta-analysis;Virology Journal;2023-11-02

2. Poxvirus-driven human diseases and emerging therapeutics;Therapeutic Advances in Infectious Disease;2022-01

3. Type I interferon signaling limits viral vector priming of CD8 + T cells during initiation of vitiligo and melanoma immunotherapy;Pigment Cell & Melanoma Research;2020-10-26

4. A replication-incompetent CD154/40L recombinant vaccinia virus induces direct and macrophage-mediated antitumor effects in vitro and in vivo;OncoImmunology;2019-02-14

5. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics;Journal for ImmunoTherapy of Cancer;2019-01-09